A partner company of Hong Kong Science and Technology Parks Corporation (HKSTP), which is a leading surgical robotics company, recently signed a high-level Memorandum of Understanding (MoU) with a longstanding clinical partner and a multispecialty private hospital in Hong Kong.
The Memorandum of Understanding will enhance the partnership between the parties, with a focus on advancing patient care, promoting technological innovations in healthcare, and fostering a culture of innovation in Hong Kong.
The two parties have a long-standing friendship, and this Memorandum of Understanding (MoU) strengthens and harmonises their partnership. Over the course of a three-year consortium, they will collaborate on various significant activities, such as exchanging scientific knowledge gained from clinical validation studies of the latest surgical robots, promoting development, and fostering new technological innovations. The goal is to transform human-assisted surgery into precise, automated solutions, improving patients’ quality of life.
The MoU was signed by the CEO of the robotics company and the CEO of the hospital. In attendance were the Secretary for Innovation, Technology and Industry; the Founder, and Chairman of the company; the Chairman of Hong Kong Automation Technology Council and Associate Director (Innovation) of a hotel group in Hong Kong as well as the Director of Peritoneal Malignancy Treatment Centre at the hospital.
The Founder of the HKSTP partner company stated that the company is committed to revolutionising surgical technologies and elevating patient care in Hong Kong and the Greater Bay Area. The support the Hong Kong government, through funding programs like the Enterprise Support Scheme and access to advanced facilities at the Science Park, has enabled PRHK to enhance its medical and surgical systems and cultivate skilled professionals. This partnership holds great potential for expanding the use of surgical robots for the benefit of patients.
Meanwhile, the CEO of the hospital noted that partnership provides both parties with a strategic platform to foster the development of technological innovations in healthcare. Drawing on the tech company’s outstanding experience in surgical robot development and implementation, we anticipate contributing to the successful transformation of our joint clinical research efforts into healthcare solutions that will offer improved care, greater precision, and more advanced options for patients.
FDA Clears SIRIUS Endoscope System for Use
SIRIUS Endoscope System, the flagship product of the robotics company, achieved 510k clearance from the United States Food and Drug Administration (FDA) in December 2022, demonstrating its safety and efficacy in use, and meeting world-class quality standards.
The CEO of the company announced that the FDA 510K clearance and the clinical data acquired through the partnership with the hospital will facilitate the company’s ability to advance its medical robotics technology in Hong Kong and the Asia Pacific region. The company’s status as a prominent leader in the development of innovative surgical robotics solutions will also be strengthened.
The robotics company is a portfolio company of the Hong Kong Science and Technology Parks Corporation (HKSTP) Venture Fund, which supports promising tech ventures by providing investment and attracting private capital. The Hong Kong Science Park is a hub for over 1,200 cutting-edge innovation and technology companies, including PRHK, in areas like artificial intelligence, robotics, biomedical technology, and more.
The CEO of HKSTP stated that the robotics company has been a consistent part of HKSTP’s ecosystem and a shining example of how research, with the right support, can lead to scalable commercial success. This collaboration represents a major milestone in their quest to improve the utilisation of robotics in healthcare, and they are thrilled to see the company’s continued growth and success.
The robotics company is dedicated to revolutionising the field of minimally invasive surgery through its innovative articulated camera system, providing advanced laparoscopic surgeries with precision, accuracy, and dependability. With the hospital’s expertise, clinical excellence, and top-notch facilities, the company aims to continue improving surgical robot applications for both surgeons and patients.
